Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #205987 on Biotech Values
iwfal
11/12/16 1:17 PM
#205990 RE: ghmm #205987
I first heard of him when he referred to advocates of Eteplirsen as Advocates of Snake Oil Salesmen (I took that as an attack on families).
ghmm
11/14/16 8:47 AM
#206026 RE: ghmm #205987
Conclusions and Recommendations The USPSTF recommends initiating use of low- to moderate-dose statins in adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year CVD event risk of 10% or greater (B recommendation). The USPSTF recommends that clinicians selectively offer low- to moderate-dose statins to adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors and a calculated 10-year CVD event risk of 7.5% to 10% (C recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating statin use in adults 76 years and older (I statement).